TGFB1 and diabetes mellitus: Guo et al. (2018) demonstrated that the oral administration of CUR at a dose of 300 mg/kg/day for 16 weeks in rats with experimental diabetes effectively reduced the production of transforming growth factor-beta1 (TGF-β1) [69].